• One-step TUNEL Cy5 Apoptosis Detection Kit Guide

  2026-09-24

  Connect DNA-fragmentation imaging to practical apoptosis workflows in cultured cells and tissue sections, with Cy5 readout options for microscopy and flow cytometry. This guide also explains how to use TUNEL as a complementary endpoint—not a substitute for pathway-specific measurements—in studies of TBK1 and type I interferon signaling.

• LNP Charge and V-ATPase Shape Nucleic Acid Delivery

  2026-09-24

  A 2026 study proposes that lipid nanoparticle (LNP) surface charge and target-cell V-ATPase activity jointly influence functional nucleic acid delivery, with contrasting patterns in cultured cells and in vivo organs. The findings connect cell-state biology to nanoparticle tropism and suggest that delivery studies should evaluate both particle properties and endo/lysosomal function.

• FGFR Crosstalk Controls Periostin in HER2+ Breast Cancer

  2026-09-24

  Labrèche et al. show that periostin expression in HER2-positive breast cancer cells is regulated by interacting FGFR, TGFβ, and PI3K/AKT signals. Their findings identify FGFR-mediated repression and SMAD-independent TGFβ induction as complementary controls, clarifying how tumor cells may acquire a periostin-positive state.

• TBST: Uses, Mechanism, and Workflow Guide

  2026-09-23

  TBST, or Tris-Buffered Saline and Tween 20, is an isotonic buffered salt solution used for blocking and washing in antibody-based assays. Its Tween 20 component can reduce nonspecific binding and support signal-to-noise ratio enhancement, while product specifications report pH 7.4 and room-temperature stability for 12 months.

• GDC-0068 (RG7440) Akt Pathway Workflow

  2026-09-22

  Build reproducible PI3K/Akt/mTOR experiments with GDC-0068 (RG7440), from dose-response and phospho-signaling assays to spatial mTORC1 studies. The workflow emphasizes biomarker selection, paradoxical phospho-Akt behavior, and controls that distinguish pathway suppression from compartment-specific effects.

• Super-Enhancer RNA Drives Nasopharyngeal Cancer Metastasis

  2026-09-22

  A 2023 study identifies the carcinogen-induced seRNA-NPCm as an active regulator of nasopharyngeal carcinoma metastasis. By integrating RNA-seq, GRO-seq, ChIP-seq, perturbation experiments, and patient-tissue analyses, the authors connect super-enhancer activity with an NPM1/c-Myc/NDRG1 transcriptional axis.

• SU5416: From VEGFR2 Biology to Translation

  2026-09-21

  SU5416 (Semaxanib) is more than a conventional angiogenesis tool: it enables controlled interrogation of VEGFR2-dependent endothelial biology while also offering an AHR-linked immune dimension. This article connects its established cancer research applications with emerging insights into vascular remodeling, including the AURKB-centered pulmonary hypertension study by Lemay et al., while defining practical safeguards for translational interpretation.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-09-21

  A 2025 study identified naturally occurring angiotensin fragments as modulators of SARS-CoV-2 spike-protein binding to AXL, ACE2, and neuropilin-1. Its peptide-length and tyrosine-modification experiments provide a structure–activity framework for connecting renin-angiotensin system research with antiviral receptor biology, while remaining primarily in vitro evidence.

• Indole-3-pyruvic acid: Bench Workflows

  2026-09-20

  Indole-3-pyruvic acid gives researchers a practical handle on auxin flux, TAA1 feedback, and AhR-linked immune assays. This workflow guide connects plant hormone research with translational immune experiments while emphasizing fresh preparation, matched controls, and domain-specific interpretation.

• GDC-0941: From PI3K Biology to Translational Strategy

  2026-09-19

  A translational perspective on using GDC-0941 to interrogate PI3K/Akt signaling, therapy resistance, and pathway-informed combination strategies in cancer research.

• GDC-0941 as a PI3K/Akt Dependency Probe

  2026-09-19

  GDC-0941 is a selective PI3K inhibitor for testing how PI3K/Akt signaling sustains cancer-cell survival, therapy resistance, and stem-like phenotypes. This article connects its pharmacology with the DRD4–Akt–β-catenin model in liver cancer and shows how to choose mechanistically informative assay readouts.

• Angiotensin Peptides and SARS-CoV-2 Receptor Binding

  2026-09-18

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects associated with shorter peptides and angiotensin IV. The work links renin–angiotensin system peptide processing to a biochemical step in viral entry while emphasizing that receptor-binding results do not by themselves establish effects on infection or disease severity.

• Leucovorin Calcium in Gastric Cancer Assays

  2026-09-17

  Leucovorin Calcium, or calcium folinate, can serve as more than a methotrexate rescue reagent. This article explains how to use its folate-bypass biology as an interpretive control in patient-derived gastric cancer assembloid assays and tumor–stroma resistance studies.

• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-09-17

  The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor transcription into stable monogenic expression in mature olfactory sensory neurons. By connecting enhancer repression with neural activity and innate olfactory behavior, the work supplies a mechanistic link between receptor-gene choice and sensory function.

• Mitoxantrone, ABCG2, and Translational Leverage

  2026-09-16

  Mitoxantrone’s topoisomerase II activity is only the first layer of translational performance. This article connects DNA damage biology with ABCG2-mediated efflux, marein-based chemosensitization, assay design, and research-use considerations for oncology and orthopoxvirus models.

7962 records 1/531 page Next 12345 下5页 Last page